North Shore-LIJ Health System, one of the largest cancer treatment providers in the New York area, and Cold Spring Harbor Laboratory (CSHL), a world-leader in cancer research, have established a transformative relationship that promises to speed the advance of novel cancer diagnostic and therapeutic discoveries. This strategic affiliation brings together CSHL scientists with the North Shore-LIJ Cancer Institute’s more than 200 academic oncologists and clinicians, who care for over 16,000 new cancer patients annually across the metropolitan area.
This unique collaboration and the proximity of the North Shore-LIJ physicians and CSHL researchers will promote the development of translational research, which applies scientific discoveries in the lab for treating select patients who could potentially benefit from early-phase clinical trials of new drugs or other therapies. This will enable North Shore-LIJ patients to receive access to the most cutting edge therapies for cancer, while receiving comprehensive, coordinated medical and surgical care as needed.
Over the next few years, the two organizations will work together to develop a new clinical cancer research unit at the North Shore-LIJ Cancer Institute's headquarters in Lake Success, NY, and recruit and train more clinician-scientists in oncology.
Learn more about the relationship between North Shore-LIJ and Cold Spring Harbor Laboratory:
The North Shore-LIJ Cancer Institute has more than 30 years of experience offering clinical trials and has enrolled more than 10,000 cancer patients in studies. At any given time, there are more than 125 cancer clinical trials being conducted and this wide range of trials provides patients access to innovative new therapies.
Cancer clinical trial studies are initiated by institute physicians, as well as by National Cancer Institute cooperative groups and other organizations.
In 2014, the institute was awarded a five-year, $4.1 million National Cancer Institute Community Oncology Research Program (NCORP) grant. The Cancer Institute was one of only 46 institutions in the United States – and the only one on Long Island – selected to participate.
To learn more about current cancer clinical trials, call (516) 734-8839.